Related Experiment Video
Updated: May 4, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Rasburicase for acute kidney injury
1Vision Care Hospital and Institute of Child Health, Kolkata, India. Correspondence to: Dr Rajiv Sinha, 37, G Bondel Road, Kolkata 700 019, India. rajivsinha_in@yahoo.com.
Rasburicase showed potential in treating acute kidney injury (AKI) by lowering serum uric acid (SUA) in one case, but its efficacy requires further investigation in diverse AKI scenarios.
Area of Science:
- Nephrology
- Pharmacology
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) presents significant mortality and morbidity.
- Novel therapeutic interventions for AKI are actively sought.
- Elevated serum uric acid (SUA) is a potential factor in AKI.
Observation:
- Two cases of AKI with elevated SUA were analyzed.
- Rasburicase was administered as a potential intervention.
- Patient demographics included a late preterm male and a 6-year-old boy with multi-organ failure.
Findings:
- In the first case, rasburicase significantly reduced SUA and improved renal parameters in a patient with AKI.
- In the second case, rasburicase did not provide significant benefit despite a decrease in SUA, even with multi-organ failure.
- The differential response suggests varied impacts of SUA reduction on AKI outcomes.
Implications:
- The therapeutic role of rasburicase in AKI warrants further clinical investigation.
- Understanding the specific mechanisms of rasburicase in different AKI contexts is crucial.
- Further studies are needed to determine rasburicase's efficacy and safety profile in AKI management.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

